Labcorp reports dip in revenue for Q2 as Covid-19 testing continues to slow in recent months

As Covid-19 testing slowed in recent months, Burlington-based Labcorp reported a small decrease in revenue for the second quarter of 2022 down to $3.7 billion and announced plans to spin-off its clinical development business.